USPTO serial 79432740
IDNAPTEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- WILLIS, ALLYSON B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with IDNAPTEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations and reagents other than for medical and veterinary use; Diagnostic screening agents for in-vitro diagnosis for scientific use; diagnostic reagents other than for medical use sold in kit form; diagnostic reagents for in-vitro use other than for medical or veterinary use; reagents for in-vitro laboratory uses other than for medical and veterinary use; chemical preparations intended for use in DNA analysis, other than for medical use; enzymes, other than for medical or veterinary use, for continuous, homogeneous and isothermal amplification processes for DNA-specific models; chemical genetic identity tests comprised of reagents for non-medical purposes; reagents for nucleic acid amplification other than for medical or veterinary use | ACTIVE | — |
| 005 | Pharmaceutical products for the prevention and treatment of cancers; preparations and reagents for diagnosis for medical or veterinary use for use in detecting cancers, in vitro diagnosis, testing blood samples; diagnostic materials being diagnostic preparations for medical or veterinary use; reagents for medical use; chemical reagents for medical or veterinary use; organic reagents for medical or veterinary use; Medical diagnostic reagents for analysis of bodily fluids for medical use; reagents for diagnostic tests for medical use; reagents for genetic testing in medicine for medical use; reagents for in vitro use in laboratories for medical use; in vitro diagnostic preparation for medical use; Biological indicators for medical diagnosis of cancers; diagnostic substances for medical use; diagnostic biomarking reagents for medical use; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, for detecting gene mutations implicated in cancers; in vitro test kits for detecting genetic defects; chemical preparations intended for use in DNA analysis for medical use; genetic identity tests comprising reagents for medical use; preparations for detecting genetic predispositions for medical use; reagents for nucleic acid amplification for medical use; diagnostic material being diagnostic preparations for medical and veterinary use | ACTIVE | — |
| 010 | Apparatus, and instruments for medical diagnosis, namely, cancer diagnosis; DNA and RNA testing apparatus for medical use; genetic testing apparatus for medical use; quantitative polymerase chain reaction (PCR) instrument for medical use, namely, thermal cycler; samplers for medical use, namely, sample preparation device for medical diagnostic use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 22, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 20, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 20, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 14, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 13, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 6, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 19, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 19, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 18, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |